ORCHID PHARMA Share Price

₹ 859.90

+₹23.45 (2.80%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: ORCHPHARMA
|
Pharmaceuticals

ORCHID PHARMA Share Price Today

As of 2 Nov 2026, ORCHID PHARMA share price is ₹859.90. The stock opened at ₹839.20, compared to its previous close of ₹836.45. During today's trading session, ORCHID PHARMA share price moved in the range of ₹821.00 to ₹861.15, with an average price of ₹841.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹480.00 and a high of ₹1,143.50. On the performance front, ORCHID PHARMA share price has increased by 33.67% over the last six months and is up 17.79% on a year-on-year basis.

Share price over the last 1 day rose from 840.00 to 859.90, ranging between 824.15 and 860.25.
₹821.00
2.80% up today
₹861.15
1D LOW
1D HIGH

ORCHID PHARMA Stock Insights

Latest Earning
Op Profit TrendDown by 89.34% QoQ
Latest Earning
Net Profit TrendDown by 89.61% QoQ
Latest Earning
Revenue TrendUp by 33.68% YoY
Stock Performance
OutperformingBeat Nifty by 37.36 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 11.62%
Shareholding Pattern
FIIFII decreased stake by 0.27%
ORCHID PHARMA stock performance
Open₹839.20
High₹861.15
Low₹821.00
Prev. close₹836.45
ORCHID PHARMA trading activity
Volume1,09,484
Average traded price₹841.74
Last traded time03:29:47 02 Nov
Last traded quantity12
Circuit
L
H
₹669.20
₹1,003.70
52-week
L
H
₹480.00
₹1,143.50
Mkt Cap Cr
4,988.74
P/E
465.39
P/B
3.19
ROA
0.62%
ROE
1.34%
ROCE
1.62%
Quick Ratio
1.13
EV/EBITDA
83.18

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Orchid Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Orchid Pharma appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Orchid Pharma earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ORCHID PHARMA Company Background

ISIN
INE191A01027
Sector Market Cap
₹ 4,988.74 Cr

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, and Veterinary Products. Its formulations include Cefixime Capsules, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc. and Diakron Pharmaceuticals, Inc.

ORCHID PHARMA Financial Highlights

  • Revenue: ORCHID PHARMA reported revenue of ₹1,269.20 crore in FY26 vs ₹949.40 crore in FY25. It showed an increase of 33.68% on a yearly basis.
  • Operating Profit: ORCHID PHARMA reported an operating profit of ₹10.43 crore in FY26 vs ₹95.56 crore in FY25. It showed a decrease of 89.09% on a year-on-year basis.
  • Net Profit: ORCHID PHARMA reported a net profit of ₹10.62 crore in FY26 vs ₹95.76 crore in FY25. It showed a decrease of 88.91% on a yearly basis.

ORCHID PHARMA Quarterly Result Highlights

  • ORCHID PHARMA reported revenue of ₹306.00 crore in Jun 2026, compared with ₹376.10 crore in Mar 2026, representing a decrease of 18.64% on a quarter-on-quarter (QoQ) basis.
  • ORCHID PHARMA reported an operating profit of ₹2.65 crore in Jun 2026, compared with ₹24.85 crore in Mar 2026, representing a decrease of 89.34% on a quarter-on-quarter (QoQ) basis.
  • ORCHID PHARMA reported a profit of ₹2.58 crore in Jun 2026, compared with ₹24.84 crore in Mar 2026, reflecting a decrease of 89.61% on a QoQ basis.
  • The earnings per share (EPS) of ORCHID PHARMA stood at ₹1.66 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
74.45%
FII
0.93%
Other DII
0.56%
Retail and other
7.18%
Mutual funds
16.88%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.87%
Jun 20260.81%
Aug 20260.93%
Sep 20260.93%

ORCHID PHARMA Investment Returns

1 day
-6.37%
1 week
+1.60%
1 month
-16.10%
1 year
+17.79%
3 years
+80.33%
5 years
+109.98%

ORCHID PHARMA Share Price History

ORCHID PHARMA share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹893.45 / ₹836.45
-6.37%
29 Oct 26
₹868.30 / ₹893.40
+3.28%
28 Oct 26
₹835.00 / ₹865.00
+3.55%
27 Oct 26
₹818.35 / ₹835.35
+2.08%
Show more

ORCHID PHARMA Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,232.78₹1,397.61₹819.37₹665.90
Other Income₹36.42₹31.98₹30.86₹19.43
Total Revenue₹1,269.20₹1,429.59₹850.23₹685.33
Total Expenses₹1,251.44₹1,308.06₹758.29₹669.29
Profit Before Tax₹10.43₹121.53₹91.95₹55.25
Tax-₹0.19-₹9.64-₹3.12₹0.00
Profit After Tax₹10.62₹131.17₹95.06₹55.25
EPS - Basic₹1.66₹22.55₹19.06₹11.35
EPS - Diluted₹1.66₹22.55₹19.06₹11.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹10.43₹121.53₹89.05₹46.32
Income before WC changes₹52.41₹161.85₹133.20₹97.70
Change in Assets₹27.32-₹66.52-₹55.43-₹87.17
Change in Liabilities₹43.56-₹28.81₹47.59₹8.10
Change in WC₹70.88-₹95.33-₹7.84-₹79.06
Cash flow from Operations₹125.64₹51.37₹125.99₹18.34
Cash flow from Investing-₹276.88-₹36.48-₹312.03-₹31.21
Cash flow from Financing₹137.14₹2.46₹167.04₹31.17
Total Cash Flow-₹14.10₹17.34-₹19.00₹18.29
Cash (Start of the year)₹21.18₹3.83₹22.60₹4.31
Cash (End of the year)₹7.07₹21.18₹3.60₹22.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,329.16₹979.84₹763.12₹724.20
Current Assets₹929.26₹1,097.53₹790.75₹501.01
Total Assets₹2,258.43₹2,077.37₹1,553.87₹1,225.21
Current Liabilities₹491.21₹508.66₹259.97₹371.89
Net Current Asset₹438.05₹588.87₹530.78₹129.12
Non-Current Liabilities₹202.91₹14.77₹124.43₹164.67
Equity Capital₹1,564.31₹1,553.93₹1,169.47₹688.65
Total Equity & Liabilities₹2,258.43₹2,077.37₹1,553.87₹1,225.21

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,232.78₹1,397.61₹819.37₹665.90
Other Income₹56.49₹36.43₹30.39₹19.43
Total Revenue₹1,289.27₹1,434.04₹849.76₹685.33
Total Expenses₹1,247.31₹1,301.60₹758.23₹669.29
Profit Before Tax₹34.62₹132.45₹91.52₹55.25
Tax₹0.00-₹9.45-₹3.23₹0.00
Profit After Tax₹34.62₹141.90₹94.75₹55.25
EPS - Basic₹5.78₹23.69₹19.59₹13.28
EPS - Diluted₹5.78₹23.69₹19.59₹13.28

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹34.62₹132.45₹91.52₹54.19
Income before WC changes₹61.33₹167.07₹133.21₹108.29
Change in Assets₹52.23-₹61.78-₹45.55-₹104.38
Change in Liabilities₹26.47-₹26.61₹42.33₹9.78
Change in WC₹78.70-₹88.39-₹3.22-₹94.60
Cash flow from Operations₹142.42₹63.54₹130.73₹13.39
Cash flow from Investing-₹116.32-₹50.80-₹315.81-₹26.70
Cash flow from Financing-₹40.74₹2.68₹167.07₹31.17
Total Cash Flow-₹14.64₹15.41-₹18.01₹17.86
Cash (Start of the year)₹15.94₹0.53₹18.31₹0.45
Cash (End of the year)₹1.30₹15.94₹0.29₹18.31

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,216.19₹1,009.49₹769.91₹729.46
Current Assets₹881.44₹1,076.54₹782.29₹493.79
Total Assets₹2,097.63₹2,086.03₹1,552.20₹1,223.26
Current Liabilities₹395.04₹460.52₹209.67₹326.63
Net Current Asset₹486.40₹616.02₹572.62₹167.16
Non-Current Liabilities₹55.92₹14.77₹124.21₹164.67
Equity Capital₹1,646.68₹1,610.74₹1,218.32₹731.96
Total Equity & Liabilities₹2,097.63₹2,086.03₹1,552.20₹1,223.26
* All values are in INR Crore
ORCHID PHARMA market depth
Bid quantityBid priceAsk priceAsk quantity
1000847.300
0000
0000
0000
0000
Total bid quantity1,000
Total ask quantity0
ORCHID PHARMA technical summary
Bearish indicators2
Neutral indicators4
Bullish indicators2
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
35.82
Neutral
ATR (14)
40.76
Neutral
STOCH(9,6)
20.69
Bullish
STOCH RSI (14)
51.73
Neutral
ADX(9)
32.06
Bearish
UO(9)
39.22
Neutral
ROC(12)
-12.87
Bearish
WillR(14)
-85.56
Bullish
Period
Simple value
Exponential vaue
5D
849.71
857.03
10D
863.91
873.06
20D
920.16
907.42
50D
968.06
946.73
100D
980.93
926.72
Volume trend — traded volume by day
2 Nov1L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ORCHID PHARMA
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in ORCHID PHARMA

Fund name
AUM
Kotak Special Opportunities Fund
1.88%
Kotak Healthcare Fund
1.28%
ITI Pharma and Healthcare Fund
1.01%

ORCHID PHARMA Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

ORCHID PHARMA Share Price FAQs

Please be aware that ORCHID PHARMA stock prices are subject to continuous fluctuations due to various factors.